Evaluation of the effects of probiotic yoghurt on inflammation and cardiometabolic risk factors in subjects with metabolic syndrome: A randomised controlled trial

Leila Rezazadeh, Beitullah Alipour, Mohammad Asghari Jafarabadi, Bahram Pourghassem Gargari

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)


This randomised, double blind study was conducted on 44 subjects with metabolic syndrome (MetS). Participants were randomly assigned to receive 300 g daily regular yoghurt or 300 g probiotic yoghurt for 8 weeks. Serum lipid profiles, blood pressure, anthropometric measurements, and serum inflammatory factors were evaluated before and after the intervention. The inflammatory factors, low-density lipoprotein-cholesterol, total cholesterol, body fat percentage and waist to hip ratio, were not significantly different within and between the groups after intervention. A significant decrease in weight, body mass index, waist circumference, hip circumference, systolic blood pressure, diastolic blood pressure, triglyceride, and a significant increase in high-density lipoprotein cholesterol were found in probiotic yoghurt group after intervention compared with baseline. Consuming probiotic yoghurt in MetS patients did not affect the inflammatory markers and cardiometabolic risk factors significantly.

Original languageEnglish
Article number104577
Number of pages9
JournalInternational Dairy Journal
Publication statusPublished - Feb 2020
Externally publishedYes

Cite this